| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $160.3M | +22.2% |
| Cost of Revenue | $96.0M | +28.1% |
| Gross Profit | $64.4M | +14.4% |
| R&D Expense | $20.3M | +3.3% |
| SG&A Expense | $40.2M | +8.8% |
| Operating Income | -$2.9M | +57.1% |
| Pre-tax Income | -$3.8M | +54.2% |
| Income Tax | $745K | -0.4% |
| Net Income | -$4.5M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.2M | +95.0% |
| Accounts Receivable | $31.3M | +13.0% |
| Inventory | $27.7M | -44.3% |
| Current Assets | $89.0M | -7.9% |
| Total Assets | $136.2M | -10.2% |
| Current Liabilities | $30.2M | -35.0% |
| Long-term Debt | $13.2M | -18.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.6M | +7757.8% |
| Capital Expenditures | $1.5M | -44.7% |
| Investing Cash Flow | -$1.5M | +79.8% |
| Financing Cash Flow | -$4.4M | -231.4% |
| Free Cash Flow | $17.1M | +803.8% |
| +49.7% |
| EPS (Basic) | -$0.12 | +52.0% |
| EPS (Diluted) | -$0.12 | +52.0% |
| Total Liabilities |
| $54.9M |
| -25.9% |
| Stockholders' Equity | $81.4M | +4.9% |